Immediate Impact
60 standout
Citing Papers
Cancer therapy with antibodies
2024 Standout
Management of ALL in adults: 2024 ELN recommendations from a European expert panel
2024 Standout
Works of Francesco Bacci being referenced
Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia
2018
Marker Expression in Peripheral T-Cell Lymphoma: A Proposed Clinical-Pathologic Prognostic Score
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Francesco Bacci | 600 | 399 | 128 | 221 | 47 | 906 | |
| P. Caverivière | 505 | 358 | 164 | 203 | 30 | 859 | |
| C Gisselbrecht | 534 | 444 | 176 | 173 | 36 | 841 | |
| Ahmed Sawas | 536 | 478 | 161 | 295 | 67 | 985 | |
| Won-Seog Kim | 616 | 469 | 107 | 277 | 37 | 763 | |
| Anne Beaven | 539 | 499 | 170 | 205 | 86 | 925 | |
| Michael Vesely | 531 | 319 | 233 | 302 | 31 | 1.1k | |
| Young-Hyeh Ko | 475 | 413 | 194 | 278 | 23 | 942 | |
| Jean Pierre Marolleau | 390 | 317 | 181 | 218 | 53 | 950 | |
| Masahiro Yokoyama | 562 | 452 | 314 | 182 | 61 | 992 | |
| P. A. Hall | 458 | 331 | 140 | 160 | 22 | 851 |
All Works
Loading papers...